Subclinical Atrial Fibrillation and Anticoagulation: Weighing the Absolute Risks and Benefits

Circulation. 2024 Mar 26;149(13):989-992. doi: 10.1161/CIRCULATIONAHA.123.067919. Epub 2024 Mar 25.
No abstract available

Keywords: Editorials; anticoagulants, hemorrhage; atrial fibrillation; ischemic stroke; risk.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anticoagulants / adverse effects
  • Atrial Fibrillation* / diagnosis
  • Atrial Fibrillation* / drug therapy
  • Atrial Fibrillation* / epidemiology
  • Humans
  • Risk Assessment
  • Stroke* / epidemiology
  • Stroke* / etiology
  • Stroke* / prevention & control
  • Warfarin / therapeutic use

Substances

  • Warfarin
  • Anticoagulants